172@29@17@101!~!172@29@0@53!~!|news|business|earnings|ipca-laboratories-q4-pat-seen-up-106-1-yoy-to-rs-105-8-cr-prabhudas-lilladher-3814761.html!~!|controller|infinite_scroll_article.php
Moneycontrol
Financial Freedom Offer: Subscribe to Moneycontrol Pro and grab benefits worth ₹15,000/-
Last Updated : Apr 12, 2019 01:13 PM IST | Source: Moneycontrol.com

IPCA Laboratories Q4 PAT seen up 106.1% YoY to Rs. 105.8 cr: Prabhudas Lilladher

Net Sales are expected to increase by 24.2 percent Y-o-Y (up 2.5 percent Q-o-Q) to Rs. 970.8 crore, according to Prabhudas Lilladher.

Representative image
Representative image
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Prabhudas Lilladher has come out with its fourth quarter (January-March’ 19) earnings estimates for the Pharma sector. The brokerage house expects IPCA Laboratories to report net profit at Rs. 105.8 crore up 106.1% year-on-year (down 34% quarter-on-quarter).


Net Sales are expected to increase by 24.2 percent Y-o-Y (up 2.5 percent Q-o-Q) to Rs. 970.8 crore, according to Prabhudas Lilladher.


Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to rise by 54.2 percent Y-o-Y (down 27.7 percent Q-o-Q) to Rs. 167.6 crore.


Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.

First Published on Apr 12, 2019 01:13 pm
Sections